ES2032956T3 - Un metodo para producir un tranquilizante o soporifero. - Google Patents

Un metodo para producir un tranquilizante o soporifero.

Info

Publication number
ES2032956T3
ES2032956T3 ES198888300710T ES88300710T ES2032956T3 ES 2032956 T3 ES2032956 T3 ES 2032956T3 ES 198888300710 T ES198888300710 T ES 198888300710T ES 88300710 T ES88300710 T ES 88300710T ES 2032956 T3 ES2032956 T3 ES 2032956T3
Authority
ES
Spain
Prior art keywords
soporifero
quiet
produce
prostaglandinas
dihidro
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES198888300710T
Other languages
English (en)
Spanish (es)
Inventor
Ryuzo Ueno
Ryuji Ueno
Ichie Kato
Tomio Oda
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Ueno Seiyaku Oyo Kenkyujo KK
Original Assignee
Ueno Seiyaku Oyo Kenkyujo KK
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ueno Seiyaku Oyo Kenkyujo KK filed Critical Ueno Seiyaku Oyo Kenkyujo KK
Application granted granted Critical
Publication of ES2032956T3 publication Critical patent/ES2032956T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C405/00—Compounds containing a five-membered ring having two side-chains in ortho position to each other, and having oxygen atoms directly attached to the ring in ortho position to one of the side-chains, one side-chain containing, not directly attached to the ring, a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, and the other side-chain having oxygen atoms attached in gamma-position to the ring, e.g. prostaglandins ; Analogues or derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/557—Eicosanoids, e.g. leukotrienes or prostaglandins
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00—Technologies relating to chemical industry
    • Y02P20/50—Improvements relating to the production of bulk chemicals
    • Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Plant Substances (AREA)
ES198888300710T 1987-01-28 1988-01-28 Un metodo para producir un tranquilizante o soporifero. Expired - Lifetime ES2032956T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP1882187 1987-01-28

Publications (1)

Publication Number Publication Date
ES2032956T3 true ES2032956T3 (es) 1993-03-01

Family

ID=11982228

Family Applications (1)

Application Number Title Priority Date Filing Date
ES198888300710T Expired - Lifetime ES2032956T3 (es) 1987-01-28 1988-01-28 Un metodo para producir un tranquilizante o soporifero.

Country Status (8)

Country Link
US (3) US5073569A (enExample)
EP (1) EP0281239B1 (enExample)
KR (1) KR930006201B1 (enExample)
AT (1) ATE74126T1 (enExample)
CA (1) CA1322749C (enExample)
DE (1) DE3869444D1 (enExample)
ES (1) ES2032956T3 (enExample)
GR (1) GR3004281T3 (enExample)

Families Citing this family (45)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2209939B (en) * 1987-09-18 1992-01-02 R Tech Ueno Ltd The use of 13,14-dihydro-15-keto-prostaglandins as ocular hypotensive agents
US6420422B1 (en) 1987-09-18 2002-07-16 Sucampo Pharmaceuticals, Inc. Ocular hypotensive agents
US5212200A (en) * 1987-09-18 1993-05-18 R-Tech Ueno, Ltd. Ocular hypotensive agents
JP2597629B2 (ja) 1988-02-26 1997-04-09 株式会社 上野製薬応用研究所 １３，１４−ジヒドロ−１５−ケトプロスタグランジン類の安定化
ES2317964T5 (es) * 1988-09-06 2015-02-20 Pfizer Health Ab Derivado de prostaglandina-F2alfa para el tratamiento de glaucoma o hipertensión ocular
US5321128A (en) * 1988-09-06 1994-06-14 Kabi Pharmacia Ab Prostaglandin derivatives for the treatment of glaucoma or ocular hypertension
US5296504A (en) * 1988-09-06 1994-03-22 Kabi Pharmacia Prostaglandin derivatives for the treatment of glaucoma or ocular hypertension
US6187813B1 (en) 1990-04-10 2001-02-13 Pharmacia & Upjohn Aktiebolag Prostaglandin derivatives for the treatment of glaucoma or ocular hypertension
US5234954A (en) * 1989-07-27 1993-08-10 K.K. Ueno Seiyaku Oyo Kenkyujo Treatment of hyperlipidemia with 15-keto-prostaglandin compounds
ATE122563T1 (de) * 1989-07-27 1995-06-15 Ueno Seiyaku Oyo Kenkyujo Kk Verwendung von 15-keto-prostansäure-derivaten zur herstellung eines medikaments für die verbesserung der ausscheidung des kaliumions.
CA2022372C (en) * 1989-08-09 2000-05-02 Ryuji Ueno Improvement of excretion of nonprotein nitrogen into the intestine by prostanoic acid derivatives
CA2027814C (en) * 1989-10-20 1996-07-30 Ryuji Ueno Treatment of hepatobiliary disease with 15-keto-prostaglandin compounds
US5256696A (en) * 1989-11-22 1993-10-26 Kabushikikaisha Ueno Seiyaku Oyo Kenkyujo Treatment of cardiac dysfunction with 15-ketoprostaglandin compounds
CA2030345C (en) * 1989-11-22 1998-12-08 Ryuji Ueno Use of 15-keto-prostaglandin compound for improvement of encephalic function
US5254588A (en) * 1989-11-22 1993-10-19 Kabushikikaisha Ueno Seiyaku Oyo Kenkyujo Treatment of pulmonary dysfunction with 15-ketoprostaglandin compounds
TW224942B (enExample) * 1990-04-04 1994-06-11 Adka Ueno Kk
CA2046069C (en) * 1990-07-10 2002-04-09 Ryuji Ueno Treatment of inflammatory diseases with 15-keto-prostaglandin compounds
DK0503887T3 (da) * 1991-03-14 1996-09-16 R Tech Ueno Ltd Fremme af sårheling med 15-ketoprostaglandinforbindelser
ES2211083T3 (es) 1998-05-25 2004-07-01 Taisho Pharmaceutical Co., Ltd Derivado de prostaglandina.
JP2003527430A (ja) 2000-03-24 2003-09-16 スカンポ・アクチェンゲゼルシャフト １５−ケトプロスタグランジンまたはその誘導体を含むアポトーシス抑制剤
MXPA02009915A (es) * 2000-04-06 2003-03-27 Sucampo Ag Composicion promotora de secrecion de bilis.
TWI302100B (en) 2001-05-02 2008-10-21 Sucampo Ag Composition for treating drug-induced constipation
CA2458471C (en) 2001-08-31 2012-07-31 Sucampo Ag Prostaglandin analogs as chloride channel opener
WO2005018646A1 (ja) 2003-08-21 2005-03-03 Sucampo Ag 眼科用組成物
WO2004037268A1 (en) * 2002-10-23 2004-05-06 Sucampo Ag Prostaglandin compounds for the treatment of obesity
JP4889219B2 (ja) 2002-12-27 2012-03-07 スキャンポ・アーゲー 腹部不快感の処置のためのプロスタグランジン誘導体
US8337891B2 (en) * 2003-07-03 2012-12-25 Sucampo Ag Enteric coated composition comprising prostaglandin analogs as chloride channel opener
TWI348386B (en) * 2003-08-12 2011-09-11 R Tech Ueno Ltd Composition and method for promoting hair growth
US7321057B2 (en) * 2004-08-02 2008-01-22 R-Tech Ueno, Ltd. Method for manufacturing prostaglandin analogue
CA2595898C (en) 2005-01-27 2015-04-28 Sucampo Ag Method and composition for treating central nervous system disorders
DK1853271T3 (da) 2005-03-04 2011-01-24 Sucampo Ag Fremgangsmåde og præparat til behandling af perifere vaskulære sygdomme
US20060281818A1 (en) 2005-03-21 2006-12-14 Sucampo Ag, North Carolina State University Method for treating mucosal disorders
JP5711442B2 (ja) * 2005-04-12 2015-04-30 スキャンポ・アーゲーＳｕｃａｍｐｏ ＡＧ 胃腸障害の処置のためのプロスタグランジン化合物およびプロトンポンプ阻害剤の併用
KR20140147142A (ko) 2006-01-24 2014-12-29 가부시키가이샤 아루떼꾸 우에노 바이-사이클릭 화합물을 함유하는 약학적 조성물 및 바이-사이클릭 화합물의 안정화 방법
CN104971056A (zh) 2006-01-24 2015-10-14 株式会社·R-技术上野 软明胶胶囊制剂
JPWO2007105691A1 (ja) 2006-03-13 2009-07-30 株式会社アールテック・ウエノ 水性組成物
US8871752B2 (en) 2008-02-19 2014-10-28 Sucampo Ag Method for modulating stem cell growth
US8609729B2 (en) 2009-04-15 2013-12-17 Sucampo Ag Method for treating macular degeneration
US8569279B2 (en) * 2009-05-27 2013-10-29 Sucampo Ag Method for modulating claudin mediated functions
US9084815B2 (en) * 2009-09-16 2015-07-21 Sucampo Ag Method for treating damage induced by an anti-tumor agent, treating mucositis and treating tumor
JP2014510022A (ja) 2011-04-07 2014-04-24 スキャンポ・アーゲー 眼精疲労の処置方法
JP6193230B2 (ja) * 2011-08-05 2017-09-06 スキャンポ・アーゲーＳｕｃａｍｐｏ ＡＧ 統合失調症の処置方法
AR092821A1 (es) 2012-04-20 2015-05-06 Sucampo Ag Conjugado de derivado de acido graso-polimero
US20150057351A1 (en) 2013-08-22 2015-02-26 Sucampo Ag Method for treating neuropathic pain
AR105029A1 (es) 2015-06-19 2017-08-30 Sucampo Ag Composición farmacéutica que comprende derivado de ácido graso

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1476661A (en) * 1974-05-13 1977-06-16 American Cyanamid Co Prostaglandins
GB2209939B (en) * 1987-09-18 1992-01-02 R Tech Ueno Ltd The use of 13,14-dihydro-15-keto-prostaglandins as ocular hypotensive agents

Also Published As

Publication number Publication date
ATE74126T1 (de) 1992-04-15
US5073569A (en) 1991-12-17
KR930006201B1 (ko) 1993-07-08
EP0281239B1 (en) 1992-03-25
EP0281239A2 (en) 1988-09-07
EP0281239A3 (en) 1988-09-21
CA1322749C (en) 1993-10-05
KR880008986A (ko) 1988-09-13
US5137915A (en) 1992-08-11
DE3869444D1 (de) 1992-04-30
GR3004281T3 (enExample) 1993-03-31
US5534547A (en) 1996-07-09

Similar Documents

Publication Publication Date Title
ES2032956T3 (es) Un metodo para producir un tranquilizante o soporifero.
DE3777253D1 (de) Herzschrittmacher zur stimulierung des menschlichen herzens.
ATE110255T1 (de) Gebrauch von ghl-cu derivaten für die herstellung eines medikaments zur stimulierung des haarwachstums.
ES2168254T3 (es) Nuevas 7-sustituidas-9-(amino sustituido)-6-desmetil-6-desoxitetraciclinas.
NO924229L (no) Trombin, samt fremstilling derav
ES2129423T3 (es) Vacunas.
GR890100652A (el) Οφθαλμικη ραφη και οργανα για την εφαρμογη χρησεως της ραφης.
ATE358176T1 (de) Menschliche dnase
FI946004A0 (fi) Lääketieteellisessä toimenpiteessä käytettävä trombiiniverifraktio
IT1077901B (it) Stimolatore di tessuto vivente di tipo impiantabile
DE69210018D1 (de) Stützkörper für eine Herzklappenprothese
ES2053778T3 (es) Procedimiento para la obtencion de derivados del tiazol.
DK486587D0 (da) Gen, kodende for humane kolonistimulerende faktorer
DE3778585D1 (de) Herzschrittmacher zur stimulierung des menschlichen herzens.
ES2068188T3 (es) Grasa pulverulenta y premezcla que la contiene.
ES2058125T3 (es) Derivados de piperidina para el tratamiento del dolor.
ES2147761T3 (es) Metodo para la deteccion de alteraciones de los huesos y otros tejidos conectivos en los seres humanos y los animales.
DE3876288D1 (de) Desinfektions- und sterilisierungsmittel.
DE3852893D1 (de) Herzschrittmacher.
ES276322U (es) Grapa quirurgica esteril.
ES2063747T3 (es) Nuevos benzotiofenos que tienen actividad antialergica, asi como nuevos benzotiofenos y otros benzotiofenos seleccionados que tienen actividad para el tratamiento del sindrome de malestar respiratorio agudo.
DE3778587D1 (de) Herzschrittmacher zur stimulierung des menschlichen herzens.
ATE25969T1 (de) 1,7-diphenyl-3-methylaza-7-cyan-8-methyl-nonan zur verwendung bei der bekaempfung von krankheiten.
BG45853A3 (bg) Метод за получаване на бензамидни съединения
ATE69549T1 (de) Erzeugnisse, enthaltend gallopamil und prazosin.

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 281239

Country of ref document: ES